Cardiovascular Diseases Clinical Trial
To estimate probabilities of death by cause for a representative United States population, according to age, sex, race, occupation, industry, income, education, residence, country of birth, calendar year, and a number of other demographic and epidemiologic factors. The representative population is derived from selected Bureau of the Census files and is matched to the National Death Index maintained by the National Center for Health Statistics. The Bureau of the Census provides the data processing, coding and management necessary to complete this objective.
BACKGROUND:
The current National Longitudinal Mortality Study began in 1983 with agreements with the
Census Bureau which prepared baseline files from surveys representative of the United States
and with the National Center for Health Statistics which prepared the National Death Index
identifying deaths in the baseline populations. The baseline population of over one million
persons has been matched to the NDI on several occasions, resulting in approximately 100,000
deaths occurring in 1979 to 1989. Using available data, an analysis was conducted relating
socio-economic characteristics to subsequent mortality.
DESIGN NARRATIVE:
The NLMS is a national study of mortality over time among selected Census Bureau population
samples numbering about 2.4 million. The census samples are matched to the National Death
Index (NDI) maintained by the National Center for Health Statistics. The NDI is a file of
all U.S. deaths since 1979 and is used to determine which individuals in the Current
Population Surveys (CPS) have died. The samples are matched every other year to obtain
deaths among these cohorts. Death certificates are then purchased from the states and coded
for causes of death and other data. Mortality rates by age, sex, race, national origin,
occupation, industry, income, education, state of residence and other factors are then
obtained. The follow-up period begins with 1979, the first year covered by the NDI and ends
with 1998. The total number of deaths for these cohorts is estimated to be about 250,000.
Census samples in the NLMS are being matched to the Centers for Medicare & Medicaid Services
(CMS) medicare database. Hospitalization, physician, outpatient, and other CMS data will be
incorporated into the NLMS database for all participants meeting the Medicare age
eligibility criteria. The study continues through December, 2009.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|